ROCHE FINANCE LTD [Rocket]

Date Filed	Type	Description
02/13/2023	SC 13G/A	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2023	SC 13G/A	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2022	SC 13G/A	ROCHE FINANCE LTD reports a 1.1% stake in Tempest Therapeutics, Inc.
02/14/2022	SC 13G/A	ROCHE FINANCE LTD reports a 4.4% stake in Vaxcyte, Inc.
02/14/2022	SC 13G	ROCHE FINANCE LTD reports a 9% stake in Entrada Therapeutics, Inc.
02/14/2022	SC 13G/A	ROCHE FINANCE LTD reports a 4.8% stake in Allakos Inc.
02/14/2022	SC 13G/A	ROCHE FINANCE LTD reports a 5.8% stake in Eloxx Pharmaceuticals, Inc.
10/04/2021	SC 13G	Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
06/14/2021	SC 13G	Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
03/02/2021	SC 13G/A	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/16/2021	SC 13G	Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/16/2021	SC 13G	ROCHE FINANCE LTD reports a 8.1% stake in Aligos Therapeutics, Inc.
02/16/2021	SC 13G	Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/16/2021	SC 13G	Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/16/2021	SC 13G/A	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/16/2021	SC 13G/A	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/16/2021	SC 13G	Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
03/17/2020	SC 13G/A	ROCHE FINANCE LTD reports a 6.2% stake in Millendo Therapeutics, Inc.
12/17/2018	SC 13G	ROCHE FINANCE LTD reports a 5.9% stake in Millendo Therapeutics, Inc.
02/10/2014	SC 13G	ROCHE FINANCE LTD reports a 9% stake in Ambit Biosciences Corporation
02/06/1998	SC 13G	Form SC 13G - Statement of acquisition of beneficial ownership by individuals: